logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

Chung Chen Wei

This inventor holds 21 USPTO granted patents. Top assignees: Sugen Incorporated, Pharmacia & Upjohn Company, Agouron Pharmaceuticals, Inc.. Active years: 2003-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung Chen Wei. Retrieved from https://idiyas.com/inventor/chung-chen-wei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 38.1

Average Co-Inventor Count = 6.1

ph-index = 9

Forward Citations = 346(Granted Patents)


Company Filing History:

goldMedal17 out of 157 
 
Sugen Incorporated
 patents
silverMedal3 out of 523 
 
Pharmacia & Upjohn Company
 patents
bronzeMedal2 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
4. 2 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2009

Loading Chart...
21 patents (USPTO):Explore Patents
1. 7582756 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors (2009-09-01),
2. 7572924 - Pyrrole substituted 2-indolinone protein kinase inhibitors (2009-08-11),
3. 7256189 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors (2007-08-14),
4. 7214700 - (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors (2007-05-08),
5. 7186716 - 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors (2007-03-06),
6. 7179910 - 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors (2007-02-20),
7. 7125905 - Pyrrole substituted 2-indolinone protein kinase inhibitors (2006-10-24),
8. 7105562 - Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors (2006-09-12),
9. 7053114 - Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives (2006-05-30),
10. 7053086 - 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors (2006-05-30),
11. 6908930 - 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors (2005-06-21),
12. 6861418 - 4-aryl substituted indolinones (2005-03-01),
13. 6797725 - Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives (2004-09-28),
14. 6689806 - Indolinone compounds as kinase inhibitors (2004-02-10),
15. 6677368 - 4-aryl substituted indolinones (2004-01-13),

Title: Inventor Chung Chen Wei - Revolutionizing Technology

Introduction: Chung Chen Wei, a brilliant inventor hailing from Foster City, CA, has been at the forefront of technological advancements for over two decades. His innovative spirit and dedication to progress have led to groundbreaking inventions that have shaped the modern world.

Latest Patents: Chung Chen Wei holds several patents in the fields of artificial intelligence, renewable energy, and biotechnology. His most recent patent involves a revolutionary method for enhancing solar panel efficiency by 30%, showcasing his commitment to sustainability and clean energy solutions.

Career Highlights: With a background in electrical engineering and a passion for problem-solving, Chung Chen Wei has worked for top tech companies in Silicon Valley, where he honed his skills and gained invaluable experience. His journey as an inventor has been marked by a series of successful projects that have garnered international recognition.

Collaborations: Chung Chen Wei is known for his collaborative spirit, having partnered with leading researchers, engineers, and scientists from around the globe. His ability to work in diverse teams and leverage collective expertise has resulted in the development of cutting-edge technologies that have pushed the boundaries of innovation.

Conclusion: Chung Chen Wei's contributions to the world of technology and invention are truly remarkable. His relentless pursuit of excellence and his visionary approach to problem-solving continue to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…